Patients must have a Gynecologic Oncology Group (GOG) performance grade of 0, 1, or 2Xx_NEWLINE_xXPatients with GOG performance grade of 3 or 4Xx_NEWLINE_xXPatients must have Gynecologic Oncology Group (GOG) performance status 0, 1, or 2Xx_NEWLINE_xXPatients with GOG performance grade of 3 or 4Xx_NEWLINE_xXPatients must have a Gynecologic Oncology Group (GOG) performance grade of 0, 1, or 2Xx_NEWLINE_xXGynecologic Oncology Group (GOG) performance status 0, 1, 2Xx_NEWLINE_xXPatients with GOG performance status of 3 or 4Xx_NEWLINE_xXPatients with a GOG Performance Status of 0, 1, or 2Xx_NEWLINE_xXPatients must not be eligible for a higher priority Gynecologic Oncology Group (GOG) protocol, if one exists; in general, this would refer to any active GOG Phase III protocol or Rare Tumor protocol for the same patient populationXx_NEWLINE_xXPatients with a GOG performance status of 0, 1, or 2Xx_NEWLINE_xXPatient must have Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2Xx_NEWLINE_xXPatients must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2Xx_NEWLINE_xXPatients must have a GOG performance status of 0 or 1Xx_NEWLINE_xXPatient must have a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2 or equivalentXx_NEWLINE_xX